Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Proteome Res ; 22(3): 812-825, 2023 03 03.
Article in English | MEDLINE | ID: mdl-36723483

ABSTRACT

Protein inhibitor of activated STAT (PIAS) proteins are E3 SUMO ligases playing important roles in protein stability and signaling transduction pathways. PIAS proteins are overexpressed in the triple-negative breast cancer cell line MDA-MB-231, and PIAS knockout (KO) results in a reduction in cell proliferation and cell arrest in the S phase. However, the molecular mechanisms underlying PIAS functions in cell proliferation and cell cycle remain largely unknown. Here, we used quantitative SUMO proteomics to explore the regulatory role of PIAS SUMO E3 ligases upon CRISPR/Cas9 KO of individual PIAS. A total of 1422 sites were identified, and around 10% of SUMO sites were regulated following KO of one or more PIAS genes. We identified protein substrates that were either specific to individual PIAS ligase or regulated by several PIAS ligases. Ki-67 and TOP2A, which are involved in cell proliferation and epithelial-to-mesenchymal transition, are SUMOylated at several lysine residues by all PIAS ligases, suggesting a level of redundancy between these proteins. Confocal microscopy and biochemical experiments revealed that SUMOylation regulated TOP2A protein stability, while this modification is involved in the recruitment of Ki-67 nucleolar proteins containing the SUMO interacting motif. These results provide novel insights into both the redundant and specific regulatory mechanisms of cell proliferation and cell cycle mediated by PIAS SUMO E3 ligases.


Subject(s)
Proteomics , Ubiquitin-Protein Ligases , Ki-67 Antigen/metabolism , Ubiquitin-Protein Ligases/metabolism , Cell Cycle , Cell Proliferation , Small Ubiquitin-Related Modifier Proteins/genetics , Small Ubiquitin-Related Modifier Proteins/metabolism , Sumoylation
2.
Nat Commun ; 11(1): 834, 2020 02 11.
Article in English | MEDLINE | ID: mdl-32047143

ABSTRACT

The protein inhibitor of activated STAT1 (PIAS1) is an E3 SUMO ligase that plays important roles in various cellular pathways. Increasing evidence shows that PIAS1 is overexpressed in various human malignancies, including prostate and lung cancers. Here we used quantitative SUMO proteomics to identify potential substrates of PIAS1 in a system-wide manner. We identified 983 SUMO sites on 544 proteins, of which 62 proteins were assigned as putative PIAS1 substrates. In particular, vimentin (VIM), a type III intermediate filament protein involved in cytoskeleton organization and cell motility, was SUMOylated by PIAS1 at Lys-439 and Lys-445 residues. VIM SUMOylation was necessary for its dynamic disassembly and cells expressing a non-SUMOylatable VIM mutant showed a reduced level of migration. Our approach not only enables the identification of E3 SUMO ligase substrates but also yields valuable biological insights into the unsuspected role of PIAS1 and VIM SUMOylation on cell motility.


Subject(s)
Cell Movement/physiology , Protein Inhibitors of Activated STAT/metabolism , Proteomics , SUMO-1 Protein/metabolism , Small Ubiquitin-Related Modifier Proteins/metabolism , Cell Proliferation , Cytoskeletal Proteins/metabolism , Gene Knockout Techniques , HEK293 Cells , HeLa Cells , Humans , Protein Inhibitors of Activated STAT/genetics , Protein Interaction Maps , SUMO-1 Protein/genetics , Sequence Analysis, Protein , Small Ubiquitin-Related Modifier Proteins/genetics , Sumoylation , Ubiquitin-Protein Ligases/metabolism , Vimentin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL